Aims: Selective atrial pacing algorithms have been developed for prevention of atrial tachycardia/atrial fibrillation (AT/AF). Although short-term studies have shown modest to minimal incremental benefit of these algorithms compared with conventional dual-chamber (DDD/R) pacing for prevention of AT/AF, the long-term effects of these algorithms are unknown. Accordingly, we compared atrial antitachycardia pacing (ATP) therapy and combined atrial ATP and atrial pace prevention (ATP + Prevention) algorithms to conventional DDD/R pacing for prevention of AT/AF over long-term follow-up.
Methods And Results: Seventy-one patients with AT/AF following pacemaker insertion were randomized to DDD/R pacing, DDD/R plus ATP pacing, or DDD/R plus ATP and prevention pacing and followed for 3 years. Atrial tachycardia/AF burden and an AF symptom scale were compared over time between groups. Atrial tachycardia/AF burden remained stable over 3 years in the DDD/R and ATP + Prevention groups. Atrial tachycardia/AF burden increased significantly over time in the ATP group. Patients not on class I or III antiarrhythmic drug therapy were more likely to experience an increase in AT/AF burden over time.
Conclusion: Atrial ATP and atrial ATP in combination with atrial pace prevention algorithms do not suppress AT/AF over long-term follow-up compared with DDD/R pacing.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/europace/eup115 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Spanish pacemaker registry. 20th official report of the Heart Rhythm Association of the Spanish Society of Cardiology (2022).
Rev Esp Cardiol (Engl Ed)
December 2023
Unidad de Electrofisiología y Arritmias, Servicio de Cardiología, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Introduction And Objectives: This article reports the cardiac pacing activity performed in 2022, including the total number of implants, adherence to remote monitoring, demographic and clinical factors, and the characteristics of the implanted devices.
Methods: The information sources were the CardioDispositivos online platform, the European pacemaker patient identification card, and data provided by the manufacturers.
Results: The rates of conventional pacemakers and low-energy resynchronizers were 866 and 34 units per million population, respectively.
Background: Dual-chamber leadless pacemakers (LPs) require robust communication between distinct right atrial (RA) and right ventricular (RV) LPs to achieve atrioventricular (AV) synchrony.
Objective: The purpose of this preclinical study was to evaluate a novel, continuous implant-to-implant (i2i™) communication methodology for maintaining AV-synchronous, dual-chamber DDD(R) pacing by the 2 LPs.
Methods: RA and RV LPs were implanted and paired in 7 ovine subjects (4 with induced complete heart block).
Predicted Need for Atrial and Ventricular Pacing Per Indication Group in Patients With Dual-Chamber Pacemakers.
Heart Lung Circ
May 2023
Amsterdam UMC location University of Amsterdam, Department of Cardiology, Amsterdam, The Netherlands; Amsterdam Cardiovascular Sciences, Heart failure & arrhythmias, Amsterdam, The Netherlands.
Article Synopsis
- Bradyarrhythmias, which are irregular heartbeats, are treated with various types of pacemakers including single-chamber and dual-chamber models, focusing on determining the best mode and device based on patient needs over time.
- A study analyzed data from 381 patients with dual-chamber pacemakers over a follow-up period of up to 6 years, highlighting that patients with sinus node dysfunction (SND) required more atrial pacing (AP), while those with complete atrioventricular block (AVB) relied heavily on ventricular pacing (VP).
- The findings indicate that different heart conditions (SND vs. complete AVB) result in distinct pacing requirements, which can influence decisions regarding the type of pacemaker and its
Patient with sick sinus syndrome and implanted dual-chamber pacemaker with reduced P-wave duration following low interatrial septal pacing: Case report.
Medicine (Baltimore)
September 2021
Department of Emergency Medical Service, Wroclaw Medical University, Wroclaw, Poland.
Introduction: A dual-chamber pacemaker (DDD/R) for a sinus node disease is sometimes referred to as a physiological pacemaker as it maintains atrioventricular synchrony, however several clinical trials have proved its inferiority to a nonphysiological single-chamber ventricular back-up pacing.
Patient Concerns: A subject of the study is a 74-year-old woman with a sick sinus syndrome (SSS) and a previously implanted physiological DDD/R pacemaker. The SSS was diagnosed because of patient's very slow sinus rhythm of about 36 bpm, and due to several episodes of dizziness.
The Story of Managed Ventricular Pacing.
J Innov Card Rhythm Manag
August 2021
Boston Scientific, Natick, MA, USA.
A significant milestone in cardiac pacing occurred approximately two decades ago, when the primary operating mode was reimagined to more closely mimic normal top-down cardiac activation. When introduced, Managed Ventricular Pacing (MVP™; Medtronic, Minneapolis, MN, USA) was an unprecedented dual-chamber mode as it preferentially paced the right atrium in the AAI/R mode and simultaneously protected against transient heart block, albeit only in the instance of dropped ventricular beats. At the time, dual-chamber DDD/R with atrial-based timing and programmable atrioventricular delay was state of the art.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!